Dr. Francis J. Cuevas
Claim this profileAscension Southeast Wisconsin Hospital - Elmbrook Campus
Studies Colorectal Cancer
Studies Lung Cancer
11 reported clinical trials
24 drugs studied
Area of expertise
1Colorectal Cancer
Stage III
Stage IV
MLH1 positive
2Lung Cancer
Stage II
Stage I
Stage IV
Affiliated Hospitals
Clinical Trials Francis J. Cuevas is currently running
Chemotherapy + Bevacizumab + Atezolizumab
for Colorectal Cancer
This phase III trial studies how well combination chemotherapy, bevacizumab, and/or atezolizumab work in treating patients with deficient deoxyribonucleic acid (DNA) mismatch repair colorectal cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as fluorouracil, oxaliplatin, and leucovorin calcium, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Bevacizumab may stop or slow colorectal cancer by blocking the growth of new blood vessels necessary for tumor growth. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving combination chemotherapy, bevacizumab, and atezolizumab may work better in treating patients with colorectal cancer.
Recruiting2 awards Phase 31 criteria
Genomic Tumor Board Review
for Cancer
This clinical trial studies how well an educationally enhanced genomic tumor board (EGTB) intervention works to increase the number of patients with solid tumors that have come back (recurrent), do not respond to treatment (refractory), have spread to other parts of the body (metastatic), or are newly diagnosed and spread to other parts of the body (advanced) who receive genome-informed treatment. Genome-informed treatment refers to treatment based on the information found in genomic tumor test results. This study compares the usual approach to reviewing genomic tumor test results with the approach of having a genomic tumor board (GTB) review the test results. A GTB is team of doctors and scientists that have experience in understanding genomic changes and review genomic tumor test results. The tumor board helps to suggest whether there are other cancer treatment options based on patient genetic test results. The usual approach is to review genomic tumor test results without the GTB being involved. This study may help researchers learn if using a GTB enhances the treatment decision making process within 6 months of joining the study. This study may also help researchers learn if using the GTB increases doctors' understanding of genomic tumor test results and increases doctors' comfort level with genomic tumor tests.
Recruiting1 award N/A
More about Francis J. Cuevas
Clinical Trial Related8 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Francis J. Cuevas has experience with
- Atezolizumab
- Nivolumab
- Oxaliplatin
- Fluorouracil
- Leucovorin
- Duloxetine
Breakdown of trials Francis J. Cuevas has run
Colorectal Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Skin Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Francis J. Cuevas specialize in?
Francis J. Cuevas focuses on Colorectal Cancer and Lung Cancer. In particular, much of their work with Colorectal Cancer has involved Stage III patients, or patients who are Stage IV.
Is Francis J. Cuevas currently recruiting for clinical trials?
Yes, Francis J. Cuevas is currently recruiting for 3 clinical trials in Brookfield Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Francis J. Cuevas has studied deeply?
Yes, Francis J. Cuevas has studied treatments such as Atezolizumab, Nivolumab, Oxaliplatin.
What is the best way to schedule an appointment with Francis J. Cuevas?
Apply for one of the trials that Francis J. Cuevas is conducting.
What is the office address of Francis J. Cuevas?
The office of Francis J. Cuevas is located at: Ascension Southeast Wisconsin Hospital - Elmbrook Campus, Brookfield, Wisconsin 53045 United States. This is the address for their practice at the Ascension Southeast Wisconsin Hospital - Elmbrook Campus.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.